VAXALTA
VaxAlta is focused on developing sugar-based, effective, affordable, and easy to administer livestock vaccines that eliminate the use of antibiotics. VaxAlta also provides contract services to clients applying its proprietary platform technology toward the development of novel glycoconjugate vaccines against any pathogen (bacteria, virus, parasite, etc) where there is a unique glycan to target.
VAXALTA
Industry:
Health Care
Founded:
2013-01-01
Address:
Edmonton, Alberta, Canada
Country:
Canada
Website Url:
http://www.vaxalta.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
U.S. Server Location
Similar Organizations
Investors List
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Pre Seed Round - VaxAlta
Official Site Inspections
http://www.vaxalta.com
- Host name: 236.119.180.107.host.secureserver.net
- IP address: 107.180.119.236
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "VaxAlta"
VaxAlta
VaxAlta Inc. For livestock industries that want to remain competitive in a changing world, VaxAlta delivers safe, sugar-based, effective, affordable, and easy to administer livestock vaccines that eliminate the use of antibiotics, helping to …See details»
VaxAlta - Crunchbase Company Profile & Funding
VaxAlta is focused on developing sugar-based, effective, affordable, and easy to administer livestock vaccines that eliminate the use of antibiotics. VaxAlta also provides contract services …See details»
Harald Nothaft - Chief Scientific Officer - VaxAlta Inc. | LinkedIn
Apr 12, 2023 Chief Scientific Officer, VaxAlta Inc.; Senior Researcher, Faculty of Science, University of Alberta · Experienced research professional with a PhD in microbiology and …See details»
VaxAlta - VentureRadar
VaxAlta also provides contract services to clients applying our proprietary platform technology toward the development of novel glycoconjugate vaccines against any pathogen (bacteria, …See details»
VaxAlta Company Profile | Management and Employees List
Find contact information for VaxAlta. Learn about their Business Services, Research & Development market share, competitors, and VaxAlta's email format.See details»
Alberta livestock vaccine research gets a $660,000 booster
VaxAlta is a leading glycoconjugate vaccine research and development company based in Edmonton, Alberta. Founded in 2013, the company is focused on developing sugar-based, …See details»
VaxAlta - Overview, News & Similar companies | ZoomInfo.com
View VaxAlta (www.vaxalta.com) location in Alberta, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
HOME - CMOCRO
VaxAlta is currently developing several glycoconjugate vaccines that target bacterial pathogens that impact animal health and human food safety. VaxAlta also provides contract services to …See details»
BioAlberta on LinkedIn: VaxAlta Inc. Announces License …
Member news: Congratulations to VaxAlta Inc., an animal health biotechnology company focused on the development of new vaccines who has entered into a licensing & collaboration …See details»
VaxAlta - Funding, Financials, Valuation & Investors
Jun 7, 2016 VaxAlta has raised 1 round.This was a Pre-Seed round raised on Jun 7, 2016. Which funding types raised the most money? Show How much funding has this organization …See details»
VaxAlta - Tech Stack, Apps, Patents & Trademarks - Crunchbase
VaxAlta is glycoconjugate vaccine research and development company.See details»
VaxAlta, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore VaxAlta, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
VaxAlta | VentureRadar
VaxAlta is currently developing several glycoconjugate vaccines that target bacterial pathogens that impact animal health and human food safety. VaxAlta also provides contract services to …See details»
VaxAlta Inc. Announces License Agreement With Scandinavian …
Dec 21, 2021 Scandinavian Biopharma has obtained a global license for VaxAlta Inc.’s intellectual property for the development of a new Campylobacter jejuni vaccine for humans. …See details»
VaxAlta Inc. Announces License Agreement With Scandinavian …
Dec 21, 2021 VaxAlta Inc., an animal health biotechnology company focused on the development of new vaccines using a novel glycoconjugate-based technology platform against …See details»
New vaccine for most common type of food poisoning
Jun 23, 2016 A team of Alberta researchers has developed a poultry vaccine that can protect against a little known but common type of food poisoning — campylobacter jejuni. “Reported …See details»
Vaxalta DMF, CEP, Written Confirmations, FDF, Prices, Patents, …
VaxAlta also provides contract services to clients applying our proprietary platform technology toward the development of novel glycoconjugate vaccines against any pathogen (bacteria, …See details»
VaxAlta - Products, Competitors, Financials, Employees, …
VaxAlta is a company focused on the development and provision of livestock vaccines, operating within the biotechnology and animal health sectors. The company's main offerings include …See details»
VaxAlta - SPEEDA Edge
VaxAlta is focused on developing sugar-based, effective, affordable, and easy to administer livestock vaccines that eliminate the use of antibiotics. VaxAlta also provides contract services …See details»
VaxAlta - Company Profile - Tracxn
What does VaxAlta do? Developer of novel glycoconjugate vaccines for livestock animals. The company develops vaccines that eliminate the use of antibiotics and help in improving animal …See details»